6/17/2014 1:24:13 PM
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today announced the addition of Jeffrey A. Chodakewitz, M.D. to the Company’s Board of Directors. Dr. Chodakewitz brings more than 30 years’ experience in infectious disease clinical research and development to the Board.
Help employers find you! Check out all the jobs and post your resume.
comments powered by